Disclosures for "Ataluren Delays Clinically Meaningful Milestones of Decline in 6WMD in Patients with nmDMD from Study 041, a Phase 3, Placebo-controlled Trial"
-
Dr. Wu has nothing to disclose.
-
Prof. Gulati has nothing to disclose.
-
Hirofumi Komaki has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Nippon Shinyaku. Hirofumi Komaki has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sarepta. The institution of Hirofumi Komaki has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for PTC therapeutics Inc. Hirofumi Komaki has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Chugai .
-
Rosa Escobar Cedillo has nothing to disclose.
-
-
Dr. Shin has nothing to disclose.
-
Dr. Haginoya has nothing to disclose.
-
Vinay Penematsa has nothing to disclose.
-
Connie Chou has stock in PTC Therapeutics.
-
Mrs. Williams has nothing to disclose.
-
Christian Werner has received personal compensation for serving as an employee of PTC Therapeutics .
-
Dr. Statland has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Arrowhead. Dr. Statland has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ML Bio. Dr. Statland has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MT Pharma. Dr. Statland has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Epic Bio. Dr. Statland has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Armatus . Dr. Statland has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Dyne Therapeutics. Dr. Statland has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Avidity . Dr. Statland has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Fulcrum Therapeutics. Dr. Statland has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. The institution of Dr. Statland has received research support from NIH. The institution of Dr. Statland has received research support from FSHD Society. The institution of Dr. Statland has received research support from Friends of FSH Research. The institution of Dr. Statland has received research support from FSHD Canada. The institution of Dr. Statland has received research support from MDA.